BAX and lymphoma: Bax is a known target gene of TRP53 and therefore, as expected, we observed an increase in Bax transcript levels in the parental Eμ-Myc lymphoma cell lines treated with Nutlin-3a compared to those treated with DMSO (vehicle, negative control).